Raj Som Pruthi - 24 Jul 2024 Form 4 Insider Report for enGene Holdings Inc. (ENGN)

Role
Chief Medical Officer
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
Issuer symbol
ENGN
Transactions as of
24 Jul 2024
Net transactions value
$0
Form type
4
Filing time
25 Jul 2024, 20:32:45 UTC
Previous filing
25 Jul 2024
Next filing
31 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENGN Stock Option (Right to Buy) Award $0 +110,000 $0.000000 110,000 24 Jul 2024 Common Shares 110,000 $8.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests at 25% on July 24, 2025, which is the first anniversary of the grant date, with the remaining portion to vest monthly over the remaining three years.